Protalix BioTherapeutics (PLX) Institutional Ownership $2.22 +0.05 (+2.30%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)CurrentInstitutional OwnershipPercentage16.53%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$986.62KNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$374.62K Get PLX Insider Trade Alerts Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PLX Institutional Buying and Selling by Quarter Protalix BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/25/2024Sanctuary Advisors LLC37,100$38K0.0%N/A0.050% 11/20/2024Virtu Financial LLC43,388$44K0.0%N/A0.059% 11/15/2024XTX Topco Ltd35,058$36K0.0%N/A0.048% 11/15/2024Jane Street Group LLC45,952$47K0.0%-84.2%0.062% 11/15/2024Point72 Asia Singapore Pte. Ltd.47,073$48K0.0%-30.9%0.064% 11/5/2024GSA Capital Partners LLP435,213$444K0.0%+8.5%0.592% 9/16/2024Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 9/16/2024Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% 8/15/2024AQR Capital Management LLC57,106$67K0.0%N/A0.078% 8/15/2024Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2024Squarepoint Ops LLC137,764$161K0.0%+673.3%0.188% 8/14/2024Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 8/9/2024Renaissance Technologies LLC804,600$941K0.0%-2.4%1.097% 8/8/2024Ground Swell Capital LLC62,234$73K0.1%N/A0.085% 5/20/2024Virtu Financial LLC157,516$198K0.0%N/A0.215% 5/7/2024 SG Americas Securities LLC21,467$27K0.0%-38.0%0.029% 5/3/2024GSA Capital Partners LLP493,571$622K0.0%-9.3%0.673% 2/2/2024Bailard Inc.68,100$121K0.0%N/A0.095% 1/19/2024Denali Advisors LLC94,700$169K0.1%-14.1%0.132% 11/15/2023GSA Capital Partners LLP496,781$825K0.1%N/A0.694% 11/13/2023Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234% 11/7/2023Barclays PLC46,511$77K0.0%+251.6%0.065% 10/27/2023Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193% 10/24/2023Bank of New York Mellon Corp165,680$275K0.0%+12.8%0.231% 10/13/2023 SG Americas Securities LLC30,008$50K0.0%N/A0.042% 9/21/2023Barclays PLC13,230$26K0.0%+561.5%0.018% 8/11/2023Natixis132,000$264K0.0%N/A0.202% 8/4/2023American International Group Inc.27,034$54K0.0%N/A0.041% 7/31/2023Orin Green Financial LLC60,150$120K0.1%N/A0.092% 7/18/2023Denali Advisors LLC110,200$220K0.1%N/A0.168% 5/10/2023Connor Clark & Lunn Investment Management Ltd.158,703$333K0.0%N/A0.243% 5/9/2023Aptus Capital Advisors LLC16,010$34K0.0%N/A0.024% 2/7/2023Commonwealth Equity Services LLC50,100$68K0.0%N/A0.101% 7/26/2022Capital Performance Advisors LLP25,974$28K0.0%N/A0.055% 5/9/2022Meitav Dash Investments Ltd.244,332$257K0.0%N/A0.527% 4/18/2022Spire Wealth Management148,800$158K0.0%+18.3%0.321% 1/31/2022Commonwealth Equity Services LLC40,290$33K0.0%N/A0.088% 1/14/2022Spire Wealth Management125,800$113K0.0%+598.9%0.276% 11/15/2021GSA Capital Partners LLP254,871$339K0.0%N/A0.559% 11/12/2021Credit Suisse AG31,974$43K0.0%-51.5%0.070% Grab This Altcoin Before Trump's Crypto Announcement (Ad)Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now8/18/2021Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 8/17/2021Walleye Capital LLC346,539$662K0.0%N/A0.764% 8/17/2021Walleye Trading LLC135,000$258K0.0%N/A0.297% 8/17/2021Bridgeway Capital Management LLC393,890$752K0.0%+30.2%0.868% 8/16/2021Morgan Stanley1,861,819$3.56M0.0%+3,723,538.0%4.102% 8/16/2021Credit Suisse AG65,925$126K0.0%+559.3%0.145% 8/13/2021Renaissance Technologies LLC30,075$57K0.0%-94.1%0.066% 8/12/2021XTX Topco Ltd17,148$33K0.0%N/A0.038% 8/11/2021Susquehanna Fundamental Investments LLC66,100$126K0.0%N/A0.146% 8/5/2021Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 5/19/2021Virtu Financial LLC27,744$124K0.0%N/A0.061% 5/18/2021Psagot Investment House Ltd.3,095,741$13.81M0.3%+558.3%6.821% 5/17/2021Schonfeld Strategic Advisors LLC89,278$399K0.0%N/A0.197% 5/17/2021DAFNA Capital Management LLC1,204,825$5.37M1.3%N/A2.655% 5/14/2021Laurion Capital Management LP42,813$191K0.0%N/A0.094% 5/14/2021Credit Suisse AG10,000$45K0.0%N/A0.022% 5/13/2021Renaissance Technologies LLC507,634$2.26M0.0%+3.9%1.119% 5/10/2021Phoenix Holdings Ltd.244,113$1.09M0.0%N/A0.538% 5/7/2021D.A. Davidson & CO.130,700$583K0.0%N/A0.288% 4/30/2021Ground Swell Capital LLC14,684$65K0.2%N/A0.032% 4/28/2021DAVENPORT & Co LLC12,000$54K0.0%N/A0.026% 2/17/2021Jane Street Group LLC22,218$81K0.0%+51.5%0.067% 2/16/2021Squarepoint Ops LLC22,068$80K0.0%-50.6%0.066% 2/4/2021GSA Capital Partners LLP10,042$36K0.0%N/A0.030% (Data available from 1/1/2016 forward) PLX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PLX shares? During the previous two years, 23 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were Renaissance Technologies LLC ($941K), GSA Capital Partners LLP ($444K), Connor Clark & Lunn Investment Management Ltd. ($278K), Bank of New York Mellon Corp ($275K), Natixis ($264K), Allspring Global Investments Holdings LLC ($229K), and Denali Advisors LLC ($169K).Learn more on PLX's institutional investors. What percentage of Protalix BioTherapeutics stock is owned by institutional investors? 16.53% of Protalix BioTherapeutics stock is owned by institutional investors. Learn more on PLX's institutional investor holdings. Which institutional investors have been buying Protalix BioTherapeutics stock? Of the 21 institutional investors that purchased Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: GSA Capital Partners LLP ($530.75K), Connor Clark & Lunn Investment Management Ltd. ($210.70K), Virtu Financial LLC ($200.90K), Allspring Global Investments Holdings LLC ($137.91K), Point72 Asia Singapore Pte. Ltd. ($136.33K), Natixis ($132K), and Squarepoint Ops LLC ($119.95K). How much institutional buying is happening at Protalix BioTherapeutics? Institutional investors have bought a total of 2,148,968 shares in the last 24 months. This purchase volume represents approximately $1.42M in transactions. Which Protalix BioTherapeutics major shareholders have been selling company stock? The following institutional investors have sold Protalix BioTherapeutics stock in the last 24 months: Jane Street Group LLC ($244.31K), GSA Capital Partners LLP ($50.67K), Point72 Asia Singapore Pte. Ltd. ($21.09K), Renaissance Technologies LLC ($20.10K), Denali Advisors LLC ($15.50K), and SG Americas Securities LLC ($13.14K). How much institutional selling is happening at Protalix BioTherapeutics? Institutional investors have sold a total of 364,803 shares in the last 24 months. This volume of shares sold represents approximately $402.21K in transactions. Related Companies Cullinan Therapeutics Major Shareholders Pharming Group Major Shareholders Arbutus Biopharma Major Shareholders Immunome Major Shareholders Evolus Major Shareholders LENZ Therapeutics Major Shareholders Autolus Therapeutics Major Shareholders Erasca Major Shareholders ORIC Pharmaceuticals Major Shareholders VectivBio Major Shareholders This page (NYSE:PLX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLX Stock Alerts